LexDanaLexDanabeta
Inventor

Christoph Martin Dehnhardt

Inventor
Burnaby, CA

Overview

44→
Patents
2008–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 44 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes24%
C07CAcyclic or carbocyclic compounds11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry2%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
10,981,905Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents202110,899,732Substituted benzamides useful as sodium channel blockers202110,815,229Benzenesulfonamide compounds and their use as therapeutic agents202010,793,579Bicyclic-fused heteroaryl or aryl compounds202010,787,446Therapeutic compounds and methods of use thereof202010,766,858Substituted benzamides and methods of use thereof202010,752,623Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors202010,662,184Benzenesulfonamide compounds and their use as therapeutic agents202010,526,285Therapeutic compounds and methods of use thereof202010,329,302Bicyclic-fused heteroaryl or aryl compounds201910,316,018Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators201910,246,453Benzenesulfonamide compounds and their use as therapeutic agents201910,179,767Substituted benzamides and methods of use thereof201910,174,000Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators201910,125,098Therapeutic compounds and methods of use thereof201810,071,957N-substituted benzamides and methods of use thereof201810,022,376Pyrazolopyridines and pyrazolopyrimidines201810,022,381Triazine compounds as PI3 kinase and mTOR inhibitors201810,005,724Therapeutic compounds and methods of use thereof20189,879,022'Bicyclic-fused heteroaryl or aryl compounds'20189,771,376'N-substituted benzamides and methods of use thereof'20179,694,002'Substituted benzamides and methods of use thereof'20179,550,775'Substituted triazolopyridines and methods of use thereof'20179,546,164'Substituted benzamides and methods of use thereof'20179,518,052'Pyrazolopyridines and pyrazolopyrimidines'20169,493,429'Substituted benzoxazoles and methods of use thereof'20169,458,168'Bicyclic-fused heteroaryl or aryl compounds'20169,174,963'Triazine compounds as PI3 kinase and MTOR inhibitors'20158,952,169'N-substituted benzamides and methods of use thereof'20158,933,236'N-substituted benzamides and methods of use thereof'20158,895,544'Indazoles'20148,859,542'Triazine compounds as PI3 kinase and mTOR inhibitors'20148,748,421'Triazine compounds as P13 kinase and MTOR inhibitors'20148,575,336'Indazoles'20138,575,159'Triazine compounds as PI3 kinase and mTOR inhibitors'20138,445,486'Triazine compounds as PI3 kinase and mTOR inhibitors'20138,217,036'Triazine compounds as PI3 kinase and mTOR inhibitors'20128,039,469'Triazine compounds as PI3 kinase and mTOR inhibitors'20118,034,960'Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as cPLA2 inhibitors'20117,842,837'Process for the synthesis of C-2, C-3 substituted N-alkylated indoles useful as cPLA2 inhibitors'20107,781,427'Process for preparing quinoline compounds and products obtained therefrom'20107,582,772'Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as CPLA2 inhibitors'20097,582,771'Process for the synthesis of cPLA2 inhibitors'20097,342,119'Process for the synthesis of a CPLA2 inhibitor'2008

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2018Based in New York, NY, US· patent location history
2010–2018Patents assigned to WYETH LLC (10)· patent assignee history
2011–2020Patents assigned to PFIZER (12)· patent assignee history
2012–2013Patents assigned to DEHNHARDT CHRISTOPH MARTIN (3)· patent assignee history
2013–2014Based in Cambridge, MA, US· patent location history
2015–2021Patents assigned to XENON PHARMACEUTICALS INC (20)· patent assignee history
2015–2021Patents assigned to GENENTECH INC (15)· patent assignee history
2015–2021Based in Burnaby, CA· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
XENON PHARMACEUTICALS INC202015–2021
GENENTECH INC152015–2021
PFIZER122011–2020
WYETH LLC102010–2018
DEHNHARDT CHRISTOPH MARTINself32012–2013
Locations
LocationPatentsSpan
Burnaby, CA282015–2021
New York, New York, US142008–2018
Cambridge, Massachusetts, US22013–2014